Overview
CPD HOURS: 4.75
OVERVIEW
Asia's healthcare sector is at an inflection point. A rising middle class across ASEAN is demanding private alternatives to overcrowded public systems, medical cost inflation is outpacing general inflation, and capital is rotating fast — away from hospital consolidation toward biopharma, tech-enabled care models, and AI-driven drug discovery. For private capital, the opportunity is significant. So is the complexity.
This Masterclass is designed for investment professionals who want to move beyond the headlines and build a sharper framework for sourcing, underwriting, and exiting healthcare and life sciences investments across the region.
WHO SHOULD PARTICIPATE?
Venture Capitalists & Private Equity Leads: Specifically those targeting Healthcare, Life Sciences, and Biotech sectors.
Sector-Specific Fund Managers: Professionals looking for insights on deal sourcing, portfolio monitoring, and preparing for high-value exits.
Family Offices & Institutional Investors: Groups seeking to capitalize on the "perfect storm" of demand driven by the rising middle class in ASEAN.
C-Suite Health Tech Executives: Founders and leaders in Biotech, MedTech, and digital health looking for cross-border investment opportunities.
Strategy & Financial Consultants: Advisors focused on healthcare business design, value creation, and traditional vs. tech-oriented services.
AI Governance & Compliance Officers: Specialists interested in the integration of AI within healthcare systems and the associated regulatory frameworks.
Public-Private Partnership (PPP) Specialists: Those exploring how private alternatives can address overcrowded public systems and increase affordability profitably.
REGISTRATION DEADLINE
21 MAY 2026
Schedule
Date: 26 May 2026, Tuesday
Time: 9:45 AM - 4:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: 32 Carpenter Street, 059911
Speakers
Speaker's Profile:
Dr. Jui Lim, CEO, Singapore Innovate Pte. Ltd.
As Chief Executive Officer of SGInnovate, Dr Lim Jui has overall leadership of the organisation that is committed to helping entrepreneurial scientists build and scale Deep Tech startups. At SGInnovate, Jui and his team work closely with a wide range of partners and co-investors to back this unique group of founders, who are looking to solve global challenges with their research-based solutions. This is done through equity-based investments, access to the Deep Tech ecosystem and talent network, as well as by providing business-building support. He currently serves on the advisory boards of IPOS International, the business arm of the Intellectual Property Office of Singapore (IPOS), and several startup companies. He was previously a board member of the Building and Construction Authority (BCA) in Singapore.
Speaker's Profile:
Johnson Chen, Chief Commercial Officer, Deloitte Singapore
Johnson Chen is Chief Commercial Officer, Deloitte Singapore and an entrepreneur, investor, and institution builder with nearly three decades of experience across healthcare, financial services, and capital markets, specialising in regulated industries and enterprise transformation. He has founded and led multiple Singapore-listed and MAS-regulated enterprises, guiding organisations from inception through growth, regulatory approvals, capital formation, and IPO execution. His experience spans the full enterprise lifecycle, including the development of precision healthcare platforms, medical technology ventures, and regulated market infrastructure. He holds Master’s and Bachelor’s degrees in Manufacturing Engineering from the University of Cambridge and was awarded the Sword of Honour by the President of Singapore.
Speaker's Profile:
Dr. Gao Yujia, Assistant Group CTO, NUHS
A/Prof Gao Yujia is a Consultant Surgeon in Liver, Pancreas, and Liver Transplant Surgery at the National University Hospital in Singapore. As the Assistant Group Chief Technology Officer for the National University Health System, A/Prof Gao is involved in the research and development of immersive technology and its application in clinical care and education, and digital-twin projects. He works extensively with Mixed Reality (MR) technology, utilising MR devices to deliver cutting edge capabilities to clinicians including 3D holographic imaging, real-time computer-vision based imaged analysis, and multisource data integration. He is also responsible for the integration and implementation of 5G wireless technology for hospital infrastructure development and building of secured high-speed integrated data networks.
Speaker's Profile:
Chris De Lavigne, Partner, Financial Advisory, Deloitte (SEA)
Chris works in the Strategy, Risk & Transactions practice in Southeast Asia specialized in Corporate Strategy & M&A. He brings 30+years of experience in growth strategies, M&A, turnaround and operational excellence, focused on providing advisory services to Corporates, Financial Institutions and Governments. He has worked in both Strategy Houses and the Big 4, and has been in Southeast Asia for over 23 years. He has extensive experience in the Healthcare sectors and has focused on Value creation for clients via Transformational M&A.
Speaker's Profile:
Dr. Milind Sabnis, Director, Life Sciences & Healthcare, Strategy & Business Design, Monitor, Deloitte
Dr. Milind Sabnis is a management consultant with over a decade of experience in healthcare strategy consulting. Currently serving as the Director at Deloitte in Life Sciences & Healthcare, Dr. Sabnis previously held leadership roles at organizations such as Frost & Sullivan and Indegene. They started their career as a Surveillance Medical Officer for the World Health Organization and have considerable expertise in healthcare sectors including pharmaceuticals and biotechnology. Dr. Sabnis has contributed thought leadership as a keynote speaker and has been featured in media outlets like BBC and CNBC. They are pursuing MD in Public Health and an MBA in Business, complementing their extensive educational background with a Mastering Design Thinking from MIT Sloan School of Management.
